Oxfam
Oxfam.org.uk
Link:
http://www.oxfam.org.uk/
Oxfam GB is a development, relief, and campaigning organisation dedicated to finding lasting solutions to poverty and suffering around the world.
New health scheme launched to help world's poor
Seven developing countries in Africa and Asia will be the first to take part in a new global health campaign aimed at directing aid more effectively at the basic needs of poor countries, Britain said on Wednesday.
HIV/AIDS Workplace Implementation Manager
We seek a person with strong implementation skills and a drive to achieve results who will be based at our Regional Management Centre to manage the implementation of the Southern Africa region’s HIV/AIDS Workplace Programme.The incumbent would also be required to spend at least 30-40% of time traveling within the region.
Closing Date: 25th April 2003
For further information on these positions and an application form, please send an e-mail to: sarojobs@oxfam.org.uk quoting the relevant reference number.Oxfam is an equal opportunities employer and encourages applications from underrepresented groups. Based in Pretoria, South Africa – Fixed Term Contract – 18 Months. Please note that only shortlisted candidates will be contacted.
GlaxoSmithKline responds to Oxfam's Campaign
No bigger challenge faces the world than the need to improve access to health care in developing countries, GlaxoSmithKline CEO Jean-Pierre Garnier writes in response recent reports in Britain's Guardian and other international press regarding Oxfam's Cut the Cost campaign against world trade laws on drugs patents. Oxfam's report this week correctly identifies deep-seated barriers to the developing world's access to medicines: 'Household poverty, inadequate public spending and weak public-health infrastructures combine to place effective treatment beyond the means of the poor,' he continues. Yet the report does not focus on these real and fundamental problems. Instead, predictably and frustratingly, it chose to focus on the protection of intellectual property, demonizing the research-based pharmaceutical industry in the process, he writes.



